PACIFIC RESEARCH LABORATORIES, INC. – Trademark Portfolio
Entity Type: 03
PACIFIC RESEARCH LABORATORIES, INC. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 13 (Firearms) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include RIMROCK, ZOOVITE, EQUIVITE, SAWBONES, and SEA TABS. The owner is based in Ramona, CA.
730 Saddlebrook Drive
Ramona, CA 92065
Showing of trademarks Trademarks
Trademark Classifications
PACIFIC RESEARCH LABORATORIES, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does PACIFIC RESEARCH LABORATORIES, INC. have?
PACIFIC RESEARCH LABORATORIES, INC. has 8 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 abandoned, 1 cancelled.
What trademark classes does PACIFIC RESEARCH LABORATORIES, INC. file in?
PACIFIC RESEARCH LABORATORIES, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 13 (Firearms), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are PACIFIC RESEARCH LABORATORIES, INC.'s most well-known trademarks?
PACIFIC RESEARCH LABORATORIES, INC.'s registered trademark portfolio includes well-known marks such as RIMROCK, ZOOVITE, EQUIVITE, SAWBONES, and SEA TABS. These are among 5 currently registered trademarks in the portfolio.
What is PACIFIC RESEARCH LABORATORIES, INC.'s trademark registration success rate?
PACIFIC RESEARCH LABORATORIES, INC. has a 63% trademark registration rate, with 5 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.